Search Results 71-80 of 16263 for Levomilnacipran

  1. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

    During an initial Dose Evaluation phase (first 2 cycles) to determine Dose Limiting Toxicities (DLTs), dose combinations of pembrolizumab 200 mg followed by ...

  2. Aminolevulinic acid (oral route) - Side effects & uses - Mayo Clinic

    When you are receiving this diagnostic test, it is especially important that your healthcare professional know if you are taking any of the medicines listed ...

  3. Cancer Treatment Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and effectiveness of Avutometinib combined with adagrasib in patients with G12C Non-Small Cell Lung Cancer ( ...

  4. Skin Cancer Clinical Trials - Mayo Clinic Research

    Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

  5. Drugs and Supplements that Start with V - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...

  6. Drugs and Supplements that Start with P - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “P” to learn about drug side effects, proper use and ...

  7. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

  9. Primary Mediastinal Large B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Biological therapies, such as lenalidomide, may stimulate or suppress the immune system in different ways and stop cancer cells from growing. Drugs used in ...

  10. Iobenguane i 131 (intravenous route) - Side effects & uses - Mayo Clinic

    Levomilnacipran; Linezolid; Lisdexamfetamine; Lofepramine. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating ...